Vexas Syndrome clinical trials

Explore recruiting vexas syndrome clinical trials.

Recruiting vexas syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Vexas Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PAXIS: A randomized, double-blind, placebo-controlled dose-finding phase 2 study (Part 1) followed by an open-label period (Part 2) to assess the efficacy and safety of pacritinib in patients with VEXAS syndrome

Spain, France, Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

GFM-VEXAS-MMB: A single-arm phase II with safety run-in multicenter study of momelotinib in patients with VEXAS syndrome with or without associated myelodysplastic syndrome

France

Therapeutic exploratory (Phase II) EU CTIS Study details

VEX-AZA: Treating VEXAS Syndrome with Azacitidine. A Single-Arm, Multicenter Phase II Study on the Efficacy and Safety of Azacitidine in Patients with VEXAS Syndrome

Denmark, Finland, Sweden, Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Vexas Syndrome trials by city

Vexas Syndrome in Toronto Vexas Syndrome in Vancouver Vexas Syndrome in Montreal Vexas Syndrome in Calgary Vexas Syndrome in Edmonton Vexas Syndrome in Ottawa Vexas Syndrome in Winnipeg Vexas Syndrome in Quebec City Vexas Syndrome in Hamilton Vexas Syndrome in Kitchener Vexas Syndrome in London Vexas Syndrome in Halifax Vexas Syndrome in New York Vexas Syndrome in Los Angeles Vexas Syndrome in Chicago Vexas Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease